Advertisement

Squamous Cell Carcinoma

  • Mordechai Rosner
  • Ido Didi Fabian
Chapter

Abstract

Squamous cell carcinoma (SCC) is a malignancy that arises from the prickle–squamous cell layers of the epithelium. It can metastasize to regional lymph nodes and is potentially fatal. Most patients with SCC are 60 years of age or older. The main risk factors include ultraviolet light and actinic damage. Because of its variable clinical presentation, biopsy and histological examination are required for an accurate diagnosis. The main treatment modality is surgical excision, with microscopic monitoring of the margins or Mohs’ microsurgery. The treatment of choice for secondary orbital invasion is orbital exenteration. Keratoacanthoma is considered to be a variant of SCC.

Keywords

Squamous cell carcinoma Keratoacanthoma Skin Eyelid Periocular Tumor Malignancy Perineural spread Ultraviolet Histopathology Epidermis Prickle cells Squamous cell layer Surgery Mohs’ microsurgery Sentinel lymph node biopsy Exenteration Radiation therapy Cryotherapy Chemotherapy Carbon dioxide laser Photodynamic therapy Retinoids α-Interferon Fluorouracil Imiquimod 

References

  1. 1.
    Reifler DM, Hornblass A. Squamous cell carcinoma of the eyelid. Surv Ophthalmol. 1986;30(6):349–65.CrossRefGoogle Scholar
  2. 2.
    Malhotra R, Huilgol SC, Huynh NT, et al. The Australian Mohs database: periocular squamous cell carcinoma. Ophthalmology. 2004;111(4):617–23.CrossRefGoogle Scholar
  3. 3.
    Cook BE Jr, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology. 1999;106(4):746–50.CrossRefGoogle Scholar
  4. 4.
    Scotto J, Kopf AW, Urbach F. Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer. 1974;34(4):1333–8.CrossRefGoogle Scholar
  5. 5.
    Green A. Changing patterns in incidence of non-melanoma skin cancer. Epithelial Cell Biol. 1992;1(1):47–51.CrossRefGoogle Scholar
  6. 6.
    Lim VS, Amrith S. Declining incidence of eyelid cancers in Singapore over 13 years: population-based data from 1996 to 2008. Br J Ophthalmol. 2012;96(12):1462–5.CrossRefGoogle Scholar
  7. 7.
    Kwitko ML, Boniuk M, Zimmerman LE. Eyelid tumors with reference to lesions confused with squamous cell carcinoma. I. Incidence and errors in diagnosis. Arch Ophthalmol. 1963;69:693–7.CrossRefGoogle Scholar
  8. 8.
    Aurora AL, Blodi FC. Lesions of the eyelids: a clinico-pathological study. Surv Ophthalmol. 1970;5:94–104.Google Scholar
  9. 9.
    Maclean H, Dhillon B, Ironside J. Squamous cell carcinoma of the eyelid and the acquired immunodeficiency syndrome. Am J Ophthalmol. 1996;121(2):219–21.CrossRefGoogle Scholar
  10. 10.
    Donaldson MJ, Sullivan TJ, Whitehead KJ, et al. Squamous cell carcinoma of the eyelids. Br J Ophthalmol. 2002;86(10):1161–5.CrossRefGoogle Scholar
  11. 11.
    Yin VT, Merritt HA, Sniegowski M, et al. Eyelid and ocular surface carcinoma: diagnosis and management. Clin Dermatol. 2015;33:159–69.CrossRefGoogle Scholar
  12. 12.
    Cook BE Jr, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001;108(11):2088–98; quiz 99–100, 121CrossRefGoogle Scholar
  13. 13.
    Malhotra R, James CL, Selva D, et al. The Australian Mohs database: periocular squamous intraepidermal carcinoma. Ophthalmology. 2004;111(10):1925–9.PubMedGoogle Scholar
  14. 14.
    Faustina M, Diba R, Ahmadi MA, et al. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma. Ophthalmology. 2004;111(10):1930–2.CrossRefGoogle Scholar
  15. 15.
    McNab AA, Francis IC, Benger R, et al. Perineural spread of cutaneous squamous cell carcinoma via the orbit. Clinical features and outcome in 21 cases. Ophthalmology. 1997;104(9):1457–62.CrossRefGoogle Scholar
  16. 16.
    Bowyer JD, Sullivan TJ, Whitehead KJ, et al. The management of perineural spread of squamous cell carcinoma to the ocular adnexae. Ophthal Plast Reconstr Surg. 2003;19(4):275–81.CrossRefGoogle Scholar
  17. 17.
    Petsuksiri J, Frank SJ, Garden AS, et al. Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. Cancer. 2008;112(1):111–8.CrossRefGoogle Scholar
  18. 18.
    Inaba K, Ito Y, Suzuki S, et al. Results of radical radiotherapy for squamous cell carcinoma of the eyelid. J Radiat Res. 2013;54:1131–7.CrossRefGoogle Scholar
  19. 19.
    Luxenberg MN, Guthrie TH Jr. Chemotherapy of basal cell and squamous cell carcinoma of the eyelids and periorbital tissues. Ophthalmology. 1986;93(4):504–10.CrossRefGoogle Scholar
  20. 20.
    Couch SM, Custer PL. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy. Ophthal Plast Reconstr Surg. 2012;28(3):181–3.CrossRefGoogle Scholar
  21. 21.
    Ross AH, Kennedy CT, Collins C, et al. The use of imiquimod in the treatment of periocular tumours. Orbit. 2010;29(2):83–7.CrossRefGoogle Scholar
  22. 22.
    Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg. 2004;30(2 Pt 2):264–71.PubMedGoogle Scholar
  23. 23.
    Rossi R, Puccioni M, Mavilia L, et al. Squamous cell carcinoma of the eyelid treated with photodynamic therapy. J Chemother. 2004;16(3):306–9.CrossRefGoogle Scholar
  24. 24.
    Soysal HG, Markoc F. Invasive squamous cell carcinoma of the eyelids and periorbital region. Br J Ophthalmol. 2007;91(3):325–9.CrossRefGoogle Scholar
  25. 25.
    Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–90.CrossRefGoogle Scholar
  26. 26.
    Committee on Guidelines of Care. Task Force on Cutaneous Squamous Cell Carcinoma. Guidelines of care for cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1993;28(4):628–31.CrossRefGoogle Scholar
  27. 27.
    Edge SE. Carcinoma of the eyelid. In: Edge SE, Byrd DR, Carducci MA, Compton CA, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.Google Scholar
  28. 28.
    Crawford C, Fernelius C, Young P, et al. Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review. Clin Ophthalmol. 2011;5:1645–8.CrossRefGoogle Scholar
  29. 29.
    Sun TM, Andrew NH, O’Donnell B, et al. Periocular squamous cell carcinoma. TNM staging and recurrence. Ophthalmology. 2015;122:1512–6.Google Scholar
  30. 30.
    Howard GR, Nerad JA, Carter KD, et al. Clinical characteristics associated with orbital invasion of cutaneous basal cell and squamous cell tumors of the eyelid. Am J Ophthalmol. 1992;113(2):123–33.CrossRefGoogle Scholar
  31. 31.
    Goepfert H, Dichtel WJ, Medina JE, et al. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg. 1984;148(4):542–7.CrossRefGoogle Scholar
  32. 32.
    Cottel WI. Perineural invasion by squamous-cell carcinoma. J Dermatol Surg Oncol. 1982;8(7):589–600.CrossRefGoogle Scholar
  33. 33.
    Petter G, Haustein UF. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg. 2000;26(6):521–30.CrossRefGoogle Scholar
  34. 34.
    Loeffler M, Hornblass A. Characteristics and behavior of eyelid carcinoma (basal cell, squamous cell sebaceous gland, and malignant melanoma). Ophthalmic Surg. 1990;21(7):513–8.PubMedGoogle Scholar
  35. 35.
    Cribier B, Asch P, Grosshans E. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Dermatology. 1999;199(3):208–12.CrossRefGoogle Scholar
  36. 36.
    Schwartz RA. Keratoacanthoma: a clinico-pathologic enigma. Dermatol Surg. 2004;30(2 Pt 2):326–33; discussion 33PubMedGoogle Scholar
  37. 37.
    Hutchinson J. Morbid growths and tumours. The “crateriform ulcer of the face”, a form of acute epithelial cancer. Trans Pathol Soc Lond. 1889;40:275–81.Google Scholar
  38. 38.
    Donaldson MJ, Sullivan TJ, Whitehead KJ, et al. Periocular keratoacanthoma: clinical features, pathology, and management. Ophthalmology. 2003;110(7):1403–7.CrossRefGoogle Scholar
  39. 39.
    Grossniklaus HE, Wojno TH, Yanoff M, et al. Invasive keratoacanthoma of the eyelid and ocular adnexa. Ophthalmology. 1996;103(6):937–41.CrossRefGoogle Scholar
  40. 40.
    Leibovitch I, Huilgol SC, James CL, et al. Periocular keratoacanthoma: can we always rely on the clinical diagnosis? Br J Ophthalmol. 2005;89(9):1201–4.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Mordechai Rosner
    • 1
  • Ido Didi Fabian
    • 2
  1. 1.Department of Ophthalmology, Eye Histopathology LaboratoryGoldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv UniversityTel AvivIsrael
  2. 2.Department of Ophthalmology, Ocular Oncology CenterGoldschleger Eye Institute, Sheba Medical Center, Sackler School of Medicine, Tel Aviv UniversityTel AvivIsrael

Personalised recommendations